PATENT CLAIM ANALYSIS

Application Number: 16182443
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "235100"]

Abstract:
The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Claim (Index 9):
The method of  claim 1 , further comprising administering or having administered an effective amount of an aminobisphosphonate drug to the subject.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.15625
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15706481', '16008991', '15849062', '15652080', '15904131']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8355500121826049
- 35 USC 102 Novelty (BERT): 0.7023542448432675
- Combined Prediction Score: 0.8222304354486712
- Mean Citation Score: 733.273308
- Max Citation Score: 763.8657
- Similarity Product: 651.3907125094412

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test